Want to see HK:8156 full AI Analyst Report?
8156 Stock Chart & Stats
HK$0.22
HK$0.00(0.00%)
At close: 4:00 PM EDT
HK$0.22
HK$0.00(0.00%)
Day’s Range― - ―
52-Week RangeHK$0.07 - HK$0.44
Previous CloseN/A
Volume194.40K
Average Volume (3M)157.92K
Market Cap
HK$121.67M
Enterprise ValueHK$175.93M
Total Cash (Recent Filing)HK$12.88M
Total Debt (Recent Filing)HK$34.55M
Price to Earnings (P/E)25.9
Beta0.43
Next Earnings
Sep 25, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)<0.01
Shares Outstanding633,693,050
10 Day Avg. Volume46,340
30 Day Avg. Volume157,918
Financial Highlights & Ratios
PEG Ratio0.99
Price to Book (P/B)-2.33
Price to Sales (P/S)1.40
P/FCF Ratio-11.93
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Very Strong Revenue GrowthSustained triple-digit revenue growth signals meaningful market demand and customer traction for an application-software business. Over 2-6 months this growth can provide a larger recurring revenue base and the scale needed to absorb fixed costs, enabling a clearer path to margin recovery if cost control follows.
Improving Free Cash Flow TrendsImprovement in free cash flow indicates the company is beginning to convert revenue into cash despite negative operating cash flow. If sustained, this reduces refinancing needs, supports reinvestment and working capital, and materially improves durability of operations over the medium term.
Lean, Asset-light Operating FootprintA small headcount suggests an asset-light, scalable software model where incremental revenue can leverage existing capacity. Over months, this operating leverage can accelerate margin expansion as revenues rise, provided product-market fit and sales efficiency continue to improve.
Bears Say
Negative Stockholders' Equity & High LeverageNegative equity and elevated leverage materially weaken financial flexibility, increasing default or restructuring risk. Over the medium term, this constraint can force costly refinancing, limit investment in growth initiatives, or lead to dilution, all of which impair sustainable recovery prospects.
Negative Operating Cash FlowOngoing negative operating cash flow means core operations currently consume cash, requiring external financing or asset sales to sustain growth. This undermines runway and elevates execution risk; unless cash generation flips positive, the company faces recurring liquidity pressure over months.
Persistent Unprofitable MarginsNegative net and EBIT margins show the business is not yet converting revenue into profit. Even with high revenue growth, persistent margin deficits signal structural cost or pricing issues that must be resolved to achieve durable profitability and self-funded growth over the medium term.
8156 FAQ
What was Sinopharm Tech Holdings Limited’s price range in the past 12 months?
Sinopharm Tech Holdings Limited lowest stock price was HK$0.07 and its highest was HK$0.44 in the past 12 months.
What is Sinopharm Tech Holdings Limited’s market cap?
Sinopharm Tech Holdings Limited’s market cap is HK$121.67M.
When is Sinopharm Tech Holdings Limited’s upcoming earnings report date?
Sinopharm Tech Holdings Limited’s upcoming earnings report date is Sep 25, 2026 which is in 74 days.
How were Sinopharm Tech Holdings Limited’s earnings last quarter?
Sinopharm Tech Holdings Limited released its earnings results on Feb 26, 2026. The company reported -HK$0.006 earnings per share for the quarter, missing the consensus estimate of N/A by -HK$0.006.
Is Sinopharm Tech Holdings Limited overvalued?
According to Wall Street analysts Sinopharm Tech Holdings Limited’s price is currently Overvalued.
Does Sinopharm Tech Holdings Limited pay dividends?
Sinopharm Tech Holdings Limited does not currently pay dividends.
What is Sinopharm Tech Holdings Limited’s EPS estimate?
Sinopharm Tech Holdings Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Sinopharm Tech Holdings Limited have?
Sinopharm Tech Holdings Limited has 633,693,050 shares outstanding.
What happened to Sinopharm Tech Holdings Limited’s price movement after its last earnings report?
Sinopharm Tech Holdings Limited reported an EPS of -HK$0.006 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 7.273%.
Which hedge fund is a major shareholder of Sinopharm Tech Holdings Limited?
Currently, no hedge funds are holding shares in HK:8156
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Sinopharm Tech Holdings Limited
Sinopharm Tech Holdings Limited functions as an investment holding enterprise, with its primary focus on lottery operations across mainland China and Hong Kong. The company diversifies its activities into several key areas: it supplies both hardware and software systems for lottery services; develops and implements "Internet Plus" solutions for various industries including healthcare, government administration, property leasing, and public security; engages in the manufacturing and distribution of personal protective equipment; and offers additional services such as corporate management, supply chain optimization, data analytics, and online trading of goods. Founded in 1999 and headquartered in Sha Tin, Hong Kong, the company rebranded to Sinopharm Tech Holdings Limited in June 2019, having previously traded as China Vanguard You Champion Holdings Limited.
Technical Analysis
Aurum Pacific (China) Group Ltd.
―
YSB Inc.
―
Zhejiang Taimei Medical Technology Co Ltd Class H
―
Beijing Saimo Technology Co. Ltd. Class H
―
JST Group Corporation Limited
―